NPC in the News

NPC serves as a trusted resource on issues related to biopharmaceutical innovation, patient access, the value of medicines, and more. See below for recent articles citing NPC's research and expertise. 

Addressing Access Burdens

Pharmaceutical Executive, January 11, 2022

NPC President and CEO John M. O'Brien discusses the increasing barriers for patients to receiving needed therapies and how pharmaceutical companies are reaching out to employers directly to talk about health benefits. 

Video: Kimberly Westrich on Micro-, Macro-Level Approaches to Improve Value-Based Benefit Design

American Journal of Managed Care, January 6, 2022

The final video in a four-part series with NPC Vice President of Health Services Research Kimberly Westrich addresses future opportunities for growth regarding value-based benefits. View part onepart two, and part three of the video series. 

NPC Appoints Sharon Phares Chief Scientific Officer, January 11, 2022

STAT News, January 7, 2022

Fierce Biotech, January 7, 2022

BioSpace, January 7, 2022

Chain Drug Review, January 4, 2022

Contract Pharma, January 4, 2022

Politico Pulse, Prescription Pulse and Playbook newsletters, January 4, 2022

Pharmacy Outlook: John O’Brien, NPC

Chain Drug Review, January 3, 2022

To kick off the new year, NPC's John M. O’Brien writes in Chain Drug Review about the need for a more informed public discussion about the role that prescription drugs play in our health care system and in improving the lives of patients.